Phase II LAPACT trial of <i>nab</i>-paclitaxel (<i>nab</i>-P) plus gemcitabine (G) for patients with locally advanced pancreatic cancer (LAPC).

Pascal Hammel, Philip Agop Philip, Fabienne Portales et al.|Journal of Clinical Oncology|2018

Cited by 32